Moderna’s adapted COVID-19 vaccine that targets Omicron XBB.1.5 approved by MHRA

An adapted COVID-19 vaccine from Moderna (Spikevax) that targets the Omicron XBB 1.5 subvariant, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.

Acadia’s Nuplazid fails as treatment for schizophrenia in Phase 3 study

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

March 11, 2024

Iveric Bio’s intravitreal solution to treat GA receives FDA approval

IZERVAY is an avacincaptad pegol intravitreal solution. Credit: Astellas Pharma Inc/ PRNewswire. IVERIC bio, an Astellas company, has received clearance from the US Food and

August 7, 2023

Tandem’s chief commercial officer to resign ahead of insulin pump rollout

Listen to the article 1 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Tandem Diabetes Care’s chief commercial

August 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.